Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis ; Vol. 15, 2016
EXCLI journal ; Vol. 15, 2016
- Classification
-
Medizin, Gesundheit
- Creator
-
Bogaerts, Eliene
Paridaens, Annelies
Verhelst, Xavier
Carmeliet, Peter
Geerts, Anja
van Vlierberghe, Hans
Devisscher, Lindsey
- Handle
-
2003/35814
- URN
-
urn:nbn:de:101:1-201702173259
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bogaerts, Eliene
- Paridaens, Annelies
- Verhelst, Xavier
- Carmeliet, Peter
- Geerts, Anja
- van Vlierberghe, Hans
- Devisscher, Lindsey
Other Objects (12)
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
Endothelial specific prolyl hydroxylase domain-containing protein 2 deficiency attenuates aging-related obesity and exercise intolerance
Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O2 Switch for Cell Survival
Rolle der HIF-Prolyl Hydroxylase Enzyme in der akuten Pankreatitis
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
Endothelial specific prolyl hydroxylase domain-containing protein 2 deficiency attenuates aging-related obesity and exercise intolerance
Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O2 Switch for Cell Survival
Rolle der HIF-Prolyl Hydroxylase Enzyme in der akuten Pankreatitis
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Prolyl-3-hydroxylase 1 in idiopathic pulmonary fibrosis
Cardiac functions of the cellular oxygen sensors prolyl-4-hydroxylase domain enzymes 2 and 3
Prolyl hydroxylase inhibition prevents graft injury during liver transplantation
Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock
Endothelial specific prolyl hydroxylase domain-containing protein 2 deficiency attenuates aging-related obesity and exercise intolerance
Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O2 Switch for Cell Survival